Bank Of Hawaii Biogen Inc. Transaction History

Bank Of Hawaii

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $7,982 - $9,223	29 Added 0.86%	3,390 $965,000
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $129,819 - $147,924	506 Added 17.72%	3,361 $934,000
Q4 2022 Jan 30, 2023	BUY	$252.44 - $306.72 $720,716 - $875,685	2,855 New	2,855 $790,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $350,484 - $464,155	-1,355 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $364,291 - $462,109	1,355 New	1,355 $429,000
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $293,425 - $458,951	-1,354 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $84,942 - $107,588	305 Added 29.08%	1,354 $407,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $307,891 - $402,637	1,049 New	1,049 $371,000
Q2 2018 Aug 06, 2018	SELL	$257.52 - $306.91 $458,900 - $546,913	-1,782 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $74,137 - $104,854	285 Added 19.04%	1,782 $488,000
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $63,066 - $70,638	205 Added 15.87%	1,497 $477,000
Q3 2017 Nov 03, 2017	SELL	$281.15 - $329.69 $843 - $989	-3 Reduced 0.23%	1,292 $405,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,295	1,295 $351,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

Stay updated on Bank Of Hawaii with notifications on news.